PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2273

  1. 193 Posts.
    lightbulb Created with Sketch. 140
    given PR clearly volunteered to do this conference I can’t imagine he wants to talk about bad / ineffective results. Let’s hope the market starts to price in something for the programmes other than OA (and they aren’t even pricing that in yet !)
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.